Intravenous Nitroglycerin in the Treatment of Decompensated Heart Failure: Potential Benefits and Limitations
暂无分享,去创建一个
[1] G. Schumock,et al. Guidelines for Acute Decompensated Heart Failure Treatment , 2004, The Annals of pharmacotherapy.
[2] J. Stamler,et al. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. , 2004, The Journal of clinical investigation.
[3] U. Elkayam,et al. Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure. , 2004, The American journal of cardiology.
[4] T. Gori,et al. Nitrate tolerance: a unifying hypothesis. , 2002, Circulation.
[5] James B. Young. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial , 2002 .
[6] R. Cody,et al. A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure. , 2001, Journal of cardiac failure.
[7] J. Horowitz,et al. Nitroglycerin Tolerance in Human Vessels: Evidence for Impaired Nitroglycerin Bioconversion , 2000, Circulation.
[8] D. Harrison,et al. Role of superoxide dismutase in in vivo and in vitro nitrate tolerance , 1999, British journal of pharmacology.
[9] B. Fink,et al. Comparison of glyceryl trinitrate-induced with pentaerythrityl tetranitrate-induced in vivo formation of superoxide radicals: effect of vitamin C. , 1999, Free radical biology & medicine.
[10] U. Elkayam,et al. The role of organic nitrates in the treatment of heart failure. , 1999, Progress in cardiovascular diseases.
[11] Y. Sugishita,et al. Preventive effects of carvedilol on nitrate tolerance--a randomized, double-blind, placebo-controlled comparative study between carvedilol and arotinolol. , 1998, Journal of the American College of Cardiology.
[12] S. J. Elliott,et al. Peroxynitrite is a contractile agonist of cerebral artery smooth muscle cells. , 1998, The American journal of physiology.
[13] N. Fink,et al. Dietary supplement with vitamin C prevents nitrate tolerance. , 1998, The Journal of clinical investigation.
[14] N. Higdon,et al. Coronary vasorelaxation by nitroglycerin: involvement of plasmalemmal calcium-activated K+ channels and intracellular Ca++ stores. , 1998, The Journal of pharmacology and experimental therapeutics.
[15] S. Glasser. Clinical Mechanisms of Nitrate Action , 1998 .
[16] T. Lincoln,et al. Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP. , 1997, The Journal of clinical investigation.
[17] U. Elkayam,et al. Renal vasodilatory effect of endothelial stimulation in patients with chronic congestive heart failure. , 1996, Journal of the American College of Cardiology.
[18] U. Elkayam,et al. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. , 1995, Journal of the American College of Cardiology.
[19] D. Harrison,et al. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. , 1995, The Journal of clinical investigation.
[20] W. Hsueh,et al. Potentiation of isosorbide dinitrate effects with N-acetylcysteine in patients with chronic heart failure. , 1994, Circulation.
[21] B. Lewis,et al. Haemodynamic and neurohumoral effects of flosequinan in severe heart failure: similarities and differences compared with intravenous nitroglycerin therapy. , 1993, European heart journal.
[22] A. Bordalo e Sá. [Nitrates in the treatment of congestive heart failure]. , 1993, Revista Portuguesa de Cardiologia.
[23] S. Padmaja,et al. The reaction of no with superoxide. , 1993, Free radical research communications.
[24] S. Solomon,et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. , 1992, Journal of the American College of Cardiology.
[25] U. Elkayam. Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention. , 1991, Annals of internal medicine.
[26] F. Messerli. Cardiovascular Drug Therapy , 1996 .
[27] J. Rouleau,et al. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. , 1990, Journal of the American College of Cardiology.
[28] B. Lewis,et al. Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease. , 1990, The American journal of cardiology.
[29] J. Rouleau,et al. Captopril does not prevent nitroglycerin tolerance in heart failure. , 1990, The Canadian journal of cardiology.
[30] H. Fung,et al. Dissociation of nitrovasodilator-induced relaxation from cyclic GMP levels during in vitro nitrate tolerance. , 1990, European journal of pharmacology.
[31] E. Espiner,et al. Effect of reducing atrial pressure on atrial natriuretic factor and vasoactive hormones in congestive heart failure secondary to ischemic and nonischemic dilated cardiomyopathy. , 1989, The American journal of cardiology.
[32] C. McKay,et al. Hemodynamic and volumetric effects of venodilation with nitroglycerin in chronic mitral regurgitation. , 1987, The American journal of cardiology.
[33] F. Murad,et al. Effect of In Vivo Nitroglycerin Therapy on Endothelium‐Dependent and Independent Vascular Relaxation and Cyclic GMP Accumulation in Rat Aorta , 1987, Journal of cardiovascular pharmacology.
[34] S. Gottlieb,et al. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. , 1987, The New England journal of medicine.
[35] W. Hsueh,et al. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. , 1987, Circulation.
[36] H. Fung,et al. Nitrosothiol and nitrate tolerance. , 1986, Zeitschrift fur Kardiologie.
[37] U. Elkayam,et al. Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure. , 1985, The American journal of cardiology.
[38] F. Magrini,et al. Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema. , 1980, The American journal of cardiology.